These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9054365)

  • 21. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways.
    Bilderback TR; Gazula VR; Lisanti MP; Dobrowsky RT
    J Biol Chem; 1999 Jan; 274(1):257-63. PubMed ID: 9867838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurotrophins. I: Molecular features].
    Zazpe A; Del Río J
    Rev Med Univ Navarra; 1997; 41(3):173-9. PubMed ID: 10420923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of Trk receptor specificities using BDNF-based neurotrophin chimeras.
    Lai KO; Glass DJ; Geis D; Yancopoulos GD; Ip NY
    J Neurosci Res; 1996 Dec; 46(5):618-29. PubMed ID: 8951673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p75 and Trk: a two-receptor system.
    Chao MV; Hempstead BL
    Trends Neurosci; 1995 Jul; 18(7):321-6. PubMed ID: 7571013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
    Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E; Peterson S; Maekawa K; Matsushima H
    Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NGF binding to p75 enhances the sensitivity of sensory and sympathetic neurons to NGF at different stages of development.
    Horton A; Laramee G; Wyatt S; Shih A; Winslow J; Davies AM
    Mol Cell Neurosci; 1997; 10(3-4):162-72. PubMed ID: 9532578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule nerve growth factor analogs image receptors in vivo.
    LeSauteur L; Cheung NK; Lisbona R; Saragovi HU
    Nat Biotechnol; 1996 Sep; 14(9):1120-2. PubMed ID: 9631063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation and growth inhibition of glioma cells induced by transfer of trk A proto-oncogene.
    Kokunai T; Iguchi H; Tamaki N
    J Neurooncol; 1999 Mar; 42(1):23-34. PubMed ID: 10360476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
    Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
    Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental changes in nerve growth factor (NGF) binding and NGF receptor proteins trkA and p75 in the facial nerve.
    Vazquez E; Calzada B; Naves J; Garnacho SS; del Valle M; Vega JA; Represa J
    Anat Embryol (Berl); 1994 Jul; 190(1):73-85. PubMed ID: 7985814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation and recovery of nerve growth factor receptor mRNA in dorsal root ganglion neurons following axotomy.
    Krekoski CA; Parhad IM; Clark AW
    J Neurosci Res; 1996 Jan; 43(1):1-11. PubMed ID: 8838569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve growth factor induced stimulation of Ras requires Trk interaction with Shc but does not involve phosphoinositide 3-OH kinase.
    Hallberg B; Ashcroft M; Loeb DM; Kaplan DR; Downward J
    Oncogene; 1998 Aug; 17(6):691-7. PubMed ID: 9715270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of neuron survival during development by nerve growth factor binding to the p75 neurotrophin receptor.
    Rydén M; Hempstead B; Ibáñez CF
    J Biol Chem; 1997 Jun; 272(26):16322-8. PubMed ID: 9195937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional properties of the TRK family of neurotrophin receptors.
    Barbacid M
    Ann N Y Acad Sci; 1995 Sep; 766():442-58. PubMed ID: 7486690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity.
    Camoratto AM; Jani JP; Angeles TS; Maroney AC; Sanders CY; Murakata C; Neff NT; Vaught JL; Isaacs JT; Dionne CA
    Int J Cancer; 1997 Aug; 72(4):673-9. PubMed ID: 9259409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53 associates with trk tyrosine kinase.
    Montano X
    Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes.
    Yaar M; Eller MS; DiBenedetto P; Reenstra WR; Zhai S; McQuaid T; Archambault M; Gilchrest BA
    J Clin Invest; 1994 Oct; 94(4):1550-62. PubMed ID: 7929831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice.
    Van der Zee CE; Ross GM; Riopelle RJ; Hagg T
    Science; 1996 Dec; 274(5293):1729-32. PubMed ID: 8939868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.